The largest database of trusted experimental protocols

Human pan monocyte isolation kit

Manufactured by BioLegend
Sourced in Germany

The Human Pan Monocyte Isolation Kit is a tool used to isolate monocytes from human peripheral blood. It utilizes a combination of immunomagnetic cell separation techniques to obtain a population of monocytes.

Automatically generated - may contain errors

2 protocols using human pan monocyte isolation kit

1

Isolating Human Monocytes by Negative Selection

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated from human leukocyte packs (Gulf Coast Regional Blood Center, Houston, TX) of healthy donors by density gradient centrifugation using Ficoll-Paque PLUS (GE Healthcare Life Sciences, Pittsburgh, PA). Pan monocytes were isolated by negative selection (Human Pan Monocyte Isolation Kit from BioLegend or Miltenyi Biotec (Bergisch Gladbach, Germany)) per manufacturer’s direction. The mean (±SD) monocyte purity for donors (N=49) used in this report was 91.1±5.4%.
+ Open protocol
+ Expand
2

Generation and Characterization of MoDCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated by standard density gradient centrifugation with Ficoll Paque Plus (GE Healthcare, 17-1440-03) from human buffy coats. Buffy coats were obtained from German Red Cross (Berlin, Germany) according to the current version of the declaration of Helsinki with an approved ethic vote (Charité, Berlin Germany; EA4/071/13). Untouched CD14+ and CD14+CD16+ monocytes were isolated by negative depletion using the human PAN monocyte isolation kit (Biolegend, 480060), following the manufacturer's instructions. Monocytes were cultured in commercial ready-to-use MoDC differentiation medium containing 400 IU/ml IL-4 and 500 IU/ml GM-CSF (Miltenyi Biotec, 130-094-812) at 37°C with 5% CO2. Every two days, half of the culture medium was replaced with fresh medium. On day six, immature MoDCs were harvested, washed with PBS and resuspended in fresh medium at a density of 106 cells/ml. Cells were either treated with medium only as control, 2.5 μg/ml LPS (from Escherichia coli O111:B4, L3024-5MG) or 400 μM NiSO4 (31483, tested endotoxin-free using QCL-1000TM Endpoint Chromogenic LAL Assay (Lonza, 50-647U) according to the manufacturers protocol). For proteomic studies and flow cytometry, cells were harvested after 24 h of continuous chemical incubation; for quantitative RT-PCR, cells were incubated either for 24 h or over a 36 h period with sample collections at various time points.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!